Paid Clinical Trials in Westlake, OH
As of July 2026, 50 paid clinical trials are recruiting in Westlake, Ohio. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Westlake offers studies at sites including UH Seidman Cancer Center at Saint John Medical Center for conditions such as Crohn's Disease, Ulcerative Colitis, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Westlake
Trials by drug in Westlake
Filter results
48 clinical trials
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
ALTO-100 in Bipolar Disorder With Depression (BD-D)
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Top Research Study Locations in Westlake
Researchers run research studies in Westlake, OH at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UH Seidman Cancer Center at Saint John Medical Center | Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma | 11 |
| Gastro Intestinal Research Institute of Northern Ohio, LLC | Obesity or Overweight, Colitis, Ulcerative, Crohn's Disease | 4 |
| UHHS-Westlake Medical Center | Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Cardiotoxicity | 4 |
| North Shore Gastroenterology Research | Ulcerative Colitis, Crohn's Disease | 4 |
| Gastro Intestinal Research Institute of Northern Ohio | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis, Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| CRIOH | Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease | 2 |
| Gastro Intestinal Research Institute of Northern Ohio, LLC. | Crohn's Disease, Ulcerative Colitis | 2 |
| Northshore Gastroenterology Research | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| Altimmune Clinical Study Site | Alcohol Liver Disease | 1 |
| Clinical Research Institute of Ohio (CRIOH), LLC | Metabolic Dysfunction-associated Steatohepatitis | 1 |
| Clinical Research Institute of Ohio, LLC | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Clinical Research Institute of Ohio, LLC (CRIOH) | MASH - Metabolic Dysfunction-Associated Steatohepatitis | 1 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease | 1 |
| NorthShore Gastroenterology Research, LLC | Crohn's Disease, Ulcerative Colitis | 1 |
| SCC at St. John's Medical Center | Cervical Cancer | 1 |
| St. John Medical Center | Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer | 1 |
| UH Seidman Cancer Center | Endometrial Cancer | 1 |
| UH St. John Health Center | Adhesive Capsulitis of the Shoulder, Frozen Shoulder | 1 |
| UH Westlake Health Center | Adhesive Capsulitis of the Shoulder, Frozen Shoulder | 1 |
| Univ Hosp Westlake | Lumbar Spinal Stenosis | 1 |
| University Hospitals Health System St John Medical Center | Lumbar Spinal Stenosis | 1 |
| University Hospitals St. John Medical Center | Cutaneous Melanoma, Stage II | 1 |
| Vanda Investigational Site | Bipolar I Disorder, Schizophrenia | 1 |
Active & Upcoming Studies in Westlake (2026)
Recruiting trials in Westlake grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (16 active studies)
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · Phase 3 · National Cancer Institute (NCI)
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
Diabetes & metabolic (8 active studies)
- A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH · Phase 3 · GlaxoSmithKline
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Mental health & behavior (3 active studies)
- Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) · Bristol-Myers Squibb
- ALTO-100 in Bipolar Disorder With Depression (BD-D) · Phase 2 · Alto Neuroscience
Cardiovascular (1 active study)
Common conditions studied in Westlake
- Crohn's Disease (5 active studies)
- Ulcerative Colitis (5 active studies)
- Endometrial Clear Cell Adenocarcinoma (2 active studies)
- Endometrial Dedifferentiated Carcinoma (2 active studies)
- Endometrial Endometrioid Adenocarcinoma (2 active studies)
- Endometrial Mixed Cell Adenocarcinoma (2 active studies)
Leading research sponsors in Westlake
- Eli Lilly and Company
- NRG Oncology
- National Cancer Institute (NCI)
- Sanofi
- Boehringer Ingelheim
Frequently asked questions
How many paid clinical trials are currently recruiting in Westlake?
There are approximately 50 recruiting clinical trials in Westlake, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Westlake pay participants?
Most recruiting trials in Westlake compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Westlake?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Westlake?
The most common conditions under active study in Westlake include Crohn's Disease (5), Ulcerative Colitis (5), Endometrial Clear Cell Adenocarcinoma (2), Endometrial Dedifferentiated Carcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Westlake?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Westlake on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Westlake?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Westlake?
Recruiting research sites in Westlake include UH Seidman Cancer Center at Saint John Medical Center, Gastro Intestinal Research Institute of Northern Ohio, LLC, UHHS-Westlake Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Westlake right now?
The largest active categories in Westlake are Cancer & tumors (16), Diabetes & metabolic (8), Mental health & behavior (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.